PAMS
ARNA

Pictet Asset Management (Switzerland)’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-56,209
Closed -$5.22M – 1771
2021
Q4 		$5.22M Sell
56,209
-1,087,178
-95% -$71.6M 0.01% 820
2021
Q3 		$68.1M Buy
+1,143,387
New +$67.5M 0.08% 284

Pictet Asset Management (Switzerland)'s ARNA Position: Q1 2022 in Review

Pictet Asset Management (Switzerland) sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 56,209 shares — an estimated $5.22M sold.

Pictet Asset Management (Switzerland) first reported a position in ARNA in Q3 2021 and held it in 2 quarters. The position peaked at $68.1M in Q3 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • Pictet Asset Management (Switzerland) reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • Pictet Asset Management (Switzerland) sold 56,209 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $5.22M.
  • Pictet Asset Management (Switzerland) first reported a position in Arena Pharmaceuticals Inc in Q3 2021 and held it in 2 quarters.
  • Pictet Asset Management (Switzerland)'s Arena Pharmaceuticals Inc position peaked at $68.1M in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q1 2022, filed 13 May 2022.